Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay
Open Access
- 1 March 2000
- Vol. 88 (5) , 1037-1044
- https://doi.org/10.1002/(sici)1097-0142(20000301)88:5<1037::aid-cncr13>3.0.co;2-h
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- The Effect of Benign and Malignant Liver Disease on the Tumour Markers CA19-9 and CEAAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1998
- Combined modality therapy for stage II and stage III pancreatic carcinoma.Journal of Clinical Oncology, 1997
- Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinomaCancer, 1997
- Adjuvant or Neoadjuvant Therapy for Pancreatic Carcinoma?Digestion, 1997
- Interleukin 4 inhibits hepatocyte growth factor-induced invasion and migration of colon carcinomasJournal of Cellular Biochemistry, 1996
- Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinomaAnnals of Oncology, 1996
- Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.Journal of Clinical Oncology, 1995
- Alpha‐subunit and human chorionic gonadotropin‐β immunoreactivity in patients with malignant endocrine gastroenteropancreatic tumoursEuropean Journal of Clinical Investigation, 1994
- High Sensitivity and Specificity of CA 19-9 for Pancreatic Carcinoma in Comparison to Chronic Pancreatitis. Serological and Immunohistochemical FindingsPancreas, 1987